Tesamorelin meta-analysis in HIV-associated lipodystrophy
Endocrine
2024
Study summary
Meta-analysis assessed efficacy and safety of tesamorelin in HIV-associated lipodystrophy.
Peptides studied
Stack studied
GH Optimization Stack
Key findings
Tesamorelin increased lean mass and reduced visceral adipose tissue with predictable IGF-1 changes.
Study details
Study type
meta-analysis
Journal
Endocrine
DOI / PubMed
10.1007/s12020-024-03971-7
Year
2024
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.
